Vascepa Patient Assistance Program: Eligibility Criteria and Benefits
Vascepa, also known as icosapent ethyl, is a prescription medication used to lower triglyceride levels in adults with severe hypertriglyceridemia. The medication is available in the United States and is marketed by Amarin Pharmaceuticals. For patients who cannot afford Vascepa, the company offers a patient assistance program (PAP) that provides financial assistance and access to the medication. In this article, we will discuss the Vascepa patient assistance program criteria, eligibility requirements, and benefits.
What is the Vascepa Patient Assistance Program?
The Vascepa patient assistance program is a program designed to help eligible patients access the medication at a reduced cost or for free. The program is administered by Amarin Pharmaceuticals and is available to patients who meet certain eligibility criteria.
Eligibility Criteria
To be eligible for the Vascepa patient assistance program, patients must meet the following criteria:
* Diagnosis: Patients must have a diagnosis of severe hypertriglyceridemia, which is defined as a triglyceride level of 500 mg/dL or higher.
* Income: Patients must have a household income that is at or below 200% of the federal poverty level (FPL).
* Insurance: Patients must have commercial insurance or Medicare Part D coverage that does not cover Vascepa or does not cover the full cost of Vascepa.
* Prescription: Patients must have a valid prescription for Vascepa from a licensed healthcare provider.
Benefits of the Vascepa Patient Assistance Program
Patients who are eligible for the Vascepa patient assistance program may be able to receive the medication at a reduced cost or for free. The program offers the following benefits:
* Free medication: Eligible patients may be able to receive Vascepa for free for up to 12 months.
* Reduced copay: Eligible patients may be able to receive Vascepa at a reduced copay of up to $10 per month.
* No application fee: There is no application fee to apply for the Vascepa patient assistance program.
How to Apply for the Vascepa Patient Assistance Program
Patients who are interested in applying for the Vascepa patient assistance program can do so by visiting the Amarin Pharmaceuticals website or by contacting the program directly. The application process typically involves the following steps:
1. Obtain a prescription: Patients must have a valid prescription for Vascepa from a licensed healthcare provider.
2. Gather required documents: Patients must gather required documents, including proof of income, insurance information, and a copy of their prescription.
3. Submit an application: Patients can submit an application for the Vascepa patient assistance program online or by mail.
4. Wait for approval: Patients will be notified of their eligibility status within 2-3 business days.
Alternatives to the Vascepa Patient Assistance Program
For patients who are not eligible for the Vascepa patient assistance program, there are alternative options available. These include:
* Manufacturer coupons: Amarin Pharmaceuticals offers manufacturer coupons that can help reduce the cost of Vascepa.
* Patient assistance foundations: There are several patient assistance foundations that offer financial assistance for Vascepa.
* Generic alternatives: There are generic alternatives to Vascepa available, which may be more affordable.
Conclusion
The Vascepa patient assistance program is a valuable resource for patients who cannot afford the medication. By understanding the eligibility criteria and benefits of the program, patients can access the medication at a reduced cost or for free. Patients who are interested in applying for the program should visit the Amarin Pharmaceuticals website or contact the program directly to learn more.
Key Takeaways
* The Vascepa patient assistance program is available to patients who meet certain eligibility criteria.
* Patients must have a diagnosis of severe hypertriglyceridemia and a household income that is at or below 200% of the federal poverty level.
* Patients must have commercial insurance or Medicare Part D coverage that does not cover Vascepa or does not cover the full cost of Vascepa.
* The program offers free medication or a reduced copay of up to $10 per month.
* Patients can apply for the program online or by mail.
Frequently Asked Questions
1. Q: What is the Vascepa patient assistance program?
A: The Vascepa patient assistance program is a program designed to help eligible patients access Vascepa at a reduced cost or for free.
2. Q: What are the eligibility criteria for the Vascepa patient assistance program?
A: Patients must have a diagnosis of severe hypertriglyceridemia, a household income that is at or below 200% of the federal poverty level, and commercial insurance or Medicare Part D coverage that does not cover Vascepa or does not cover the full cost of Vascepa.
3. Q: How do I apply for the Vascepa patient assistance program?
A: Patients can apply for the program online or by mail by visiting the Amarin Pharmaceuticals website or contacting the program directly.
4. Q: What are the benefits of the Vascepa patient assistance program?
A: The program offers free medication or a reduced copay of up to $10 per month.
5. Q: Are there alternative options available for patients who are not eligible for the Vascepa patient assistance program?
A: Yes, there are alternative options available, including manufacturer coupons, patient assistance foundations, and generic alternatives.
Sources
1. Amarin Pharmaceuticals. (n.d.). Vascepa Patient Assistance Program. Retrieved from <https://www.vascepa.com/patient-assistance-program/>
2. DrugPatentWatch.com. (n.d.). Vascepa (icosapent ethyl) - Drug Information. Retrieved from <https://www.drugpatentwatch.com/drug/vascepa-icosapent-ethyl>
3. Centers for Medicare and Medicaid Services. (n.d.). Federal Poverty Level (FPL) Chart. Retrieved from <https://www.cms.gov/Regulations-and-Guidance/Legislation/PPO/Downloads/FederalPovertyLevelChart.pdf>
4. Amarin Pharmaceuticals. (2020). Vascepa (icosapent ethyl) Prescribing Information. Retrieved from <https://www.vascepa.com/prescribing-information/>
5. National Lipid Association. (n.d.). Severe Hypertriglyceridemia. Retrieved from <https://www.lipid.org/severe-hypertriglyceridemia>